Since TLO B cells were also found in the synovium of inflamed joints, Rituximab (an anti-CD20 B-cell depleting antibody) might be an alternative therapy for treating rheumatoid arthritis, besides of TNF-α and IL-1 antagonist in clinic. The gene discussed is TNF; the disease is rheumatoid arthritis.